We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ANIX market cap is 90.15M. The company's latest EPS is USD -0.3899 and P/E is -7.36.
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.05M | -3.61M | -3.47M | -3.59M | -3.16M |
| Net Income | -2.69M | -3.26M | -3.14M | -3.28M | -2.88M |
| Year End October 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 513k | 0 | 210k | 0 |
| Operating Income | -9.98M | -13.14M | -13.88M | -11.01M | -13.83M |
| Net Income | -10.02M | -12.95M | -13.6M | -9.81M | -12.55M |
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.52M | 25.37M | 24.36M | 22.91M | 21.59M |
| Total Liabilities | 2.15M | 1.77M | 1.77M | 2.22M | 2.7M |
| Total Equity | 23.37M | 23.6M | 22.58M | 20.69M | 18.89M |
| Year End October 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.45M | 36.26M | 30.41M | 25.52M | 21.59M |
| Total Liabilities | 1.19M | 1.49M | 2.21M | 2.15M | 2.7M |
| Total Equity | 8.26M | 34.77M | 28.2M | 23.37M | 18.89M |
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.21M | -2.31M | -3.77M | -6.41M | -7.34M |
| Investing | -5.6M | 129k | 685k | 3.41M | 4.28M |
| Financing | 366k | 2.26M | 3.16M | 3.31M | 3.42M |
| Year End October 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.18M | -4.94M | -6.49M | -6.21M | -7.34M |
| Investing | -306k | -3.92M | -10.73M | -5.6M | 4.28M |
| Financing | 9.41M | 31.57M | 452k | 366k | 3.42M |
| Market Cap | 90.15M |
| Price to Earnings Ratio | -7.36 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 72.66 |
| Price to Book Ratio | 4.89 |
| Dividend Yield | - |
| Shares Outstanding | 32.2M |
| Average Volume (1 week) | 74.49k |
| Average Volume (1 Month) | 95.85k |
| 52 Week Change | -30.86% |
| 52 Week High | 4.20 |
| 52 Week Low | 2.07 |
| Spread (Intraday) | 0.45 (13.85%) |
| Company Name | Anixa Biosciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.anixa.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
